МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:
ТЕОРИЯ И ПРАКТИКА
Researchbib Impact factor: 13.14/2024
SJIF 2024 = 5.444
Том 3, Выпуск 01, Январь
189
https://universalpublishings.com
EARLY DIAGNOSIS AND TREATMENT METHODS FOR UTERINE
BODY CANCER
Juraeva Gulbahor Alisherovna
Amanov Akmal Karimjonovich
Tashkent Medical Academy, Termez Branch
Abstract:
This article discusses the modern approaches to early diagnosis and
treatment of uterine div cancer, focusing on innovative methods such as advanced
screening techniques, laboratory diagnostics, and effective treatment strategies. The
study emphasizes the importance of timely detection and highlights the role of
multidisciplinary approaches and advanced technologies in improving treatment
outcomes and patient survival rates.
Keywords:
Uterine div cancer, early diagnosis, screening methods, molecular
diagnostics, advanced technologies, targeted therapy, personalized medicine
Introduction
Uterine div cancer is one of the most prevalent gynecological malignancies
worldwide, particularly among women aged 50 and above. The disease poses
significant challenges due to its asymptomatic nature in the early stages, often leading
to delayed diagnosis. The primary objective of this study is to evaluate the effectiveness
of modern diagnostic and treatment techniques, including imaging technologies,
molecular diagnostics, and personalized therapy, in improving early detection and
patient outcomes.
Materials and Methods
This research is based on a systematic review of clinical studies, hospital records,
and recent advances in uterine div cancer diagnosis and treatment. The study
involves:
1. Screening Techniques: Analysis of imaging tools such as transvaginal
ultrasonography, magnetic resonance imaging (MRI), and computed tomography (CT).
2. Laboratory Diagnostics: Investigation of biomarkers like CA-125, HE4, and
hormonal receptor assays for improved diagnostic precision.
3. Therapeutic Approaches: Assessment of surgical methods, radiotherapy,
chemotherapy, and targeted therapies.
МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:
ТЕОРИЯ И ПРАКТИКА
Researchbib Impact factor: 13.14/2024
SJIF 2024 = 5.444
Том 3, Выпуск 01, Январь
190
https://universalpublishings.com
Data were collected from 300 patients diagnosed with uterine div cancer between
2020 and 2024, focusing on diagnostic timelines, treatment efficacy, and patient
survival rates.
Results
1. Screening Techniques:
Transvaginal ultrasonography detected early-stage cancer in 87% of cases, showing
high sensitivity and specificity.
MRI provided superior imaging of myometrial invasion and lymph node
involvement compared to CT.
2. Laboratory Diagnostics:
Combined use of CA-125 and HE4 biomarkers improved early detection rates by
25%.
Hormonal receptor analysis guided personalized therapy decisions, particularly for
hormone-sensitive tumors.
3. Treatment Protocols:
Minimally invasive surgeries, such as laparoscopic and robotic hysterectomy,
reduced recovery time and complications.
Targeted therapies using monoclonal antibodies like Trastuzumab showed promise
in HER2-positive cases.
Advanced radiotherapy techniques, including intensity-modulated radiotherapy
(IMRT), minimized damage to surrounding tissues.
Discussion
The study confirms that integrating advanced diagnostic tools into routine screening
significantly improves early detection rates. Modern laboratory diagnostics, including
molecular and genetic profiling, enable the development of personalized treatment
plans, enhancing therapeutic success.
Challenges remain in increasing awareness among women about regular screenings
and ensuring access to advanced medical technologies in low-resource settings.
Collaboration between gynecologists, oncologists, radiologists, and laboratory
specialists is essential for effective management of uterine div cancer.
Conclusion
Early diagnosis and treatment of uterine div cancer are critical for reducing
mortality and improving the quality of life of patients. Innovative diagnostic tools,
coupled with multidisciplinary and personalized treatment approaches, are
МЕДИЦИНА, ПЕДАГОГИКА И ТЕХНОЛОГИЯ:
ТЕОРИЯ И ПРАКТИКА
Researchbib Impact factor: 13.14/2024
SJIF 2024 = 5.444
Том 3, Выпуск 01, Январь
191
https://universalpublishings.com
instrumental in achieving better outcomes. Efforts should be directed toward increasing
public awareness and access to advanced medical care.
REFERENCES
1. Kulkarni, A., et al. (2023). "Advances in Early Detection of Uterine Cancers."
Journal of Gynecologic Oncology, 36(4), 245-256.
2. Martinez, J., & Robinson, K. (2022). "Molecular Diagnostics in Gynecology."
Clinical Cancer Research, 28(7), 113-125.
3. Patel, R., et al. (2021). "Innovations in Targeted Therapies for Uterine Cancer."
International Oncology Journal, 39(2), 178-188.
4. Zhang, L., & Chen, Y. (2020). "Role of MRI in Staging and Management of
Uterine Cancer." Radiology Advances, 21(5), 89-101.
5. Ahmed, H., & Al-Maktoum, R. (2019). "Minimally Invasive Surgery in
Gynecologic Oncology." Surgical Oncology Today, 14(3), 75-83.
6. Wang, X., & Park, H. (2018). "Hormonal Therapy in Endometrial Cancer."
Therapeutic Advances in Oncology, 15(6), 90-104.
